Massachusetts Financial Services
UTHR icon

Massachusetts Financial Services’s United Therapeutics UTHR Stock Holding History

Massachusetts Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,066
Closed -$1.78M – 871
2023
Q2 		$1.78M Sell
8,066
-190
-2% -$42.1K ﹤0.01% 718
2023
Q1 		$1.85M Sell
8,256
-6,232
-43% -$1.54M ﹤0.01% 720
2022
Q4 		$4.03M Buy
14,488
+307
+2% +$77.5K ﹤0.01% 669
2022
Q3 		$2.97M Sell
14,181
-1,943
-12% -$434K ﹤0.01% 687
2022
Q2 		$3.8M Buy
16,124
+316
+2% +$64.2K ﹤0.01% 672
2022
Q1 		$2.84M Buy
15,808
+219
+1% +$41.7K ﹤0.01% 717
2021
Q4 		$3.37M Sell
15,589
-5,888
-27% -$1.16M ﹤0.01% 718
2021
Q3 		$3.96M Sell
21,477
-450
-2% -$88.6K ﹤0.01% 727
2021
Q2 		$3.93M Sell
21,927
-9,688
-31% -$1.85M ﹤0.01% 727
2021
Q1 		$5.29M Sell
31,615
-15,799
-33% -$2.63M ﹤0.01% 691
2020
Q4 		$7.2M Sell
47,414
-1,091
-2% -$143K ﹤0.01% 658
2020
Q3 		$4.9M Buy
48,505
+10,898
+29% +$1.2M ﹤0.01% 665
2020
Q2 		$4.55M Buy
37,607
+7,330
+24% +$825K ﹤0.01% 639
2020
Q1 		$2.87M Buy
30,277
+4,565
+18% +$434K ﹤0.01% 651
2019
Q4 		$2.27M Sell
25,712
-2,159
-8% -$190K ﹤0.01% 703
2019
Q3 		$2.22M Buy
27,871
+4,968
+22% +$400K ﹤0.01% 712
2019
Q2 		$1.79M Buy
22,903
+3,629
+19% +$339K ﹤0.01% 745
2019
Q1 		$2.26M Buy
19,274
+561
+3% +$65.4K ﹤0.01% 705
2018
Q4 		$2.04M Buy
18,713
+1,324
+8% +$154K ﹤0.01% 705
2018
Q3 		$2.22M Buy
17,389
+52
+0.3% +$6.43K ﹤0.01% 712
2018
Q2 		$1.96M Sell
17,337
-887
-5% -$97.5K ﹤0.01% 715
2018
Q1 		$2.05M Buy
18,224
+9,801
+116% +$1.25M ﹤0.01% 701
2017
Q4 		$1.25M Buy
8,423
+1,621
+24% +$206K ﹤0.01% 735
2017
Q3 		$797K Buy
+6,802
New +$869K ﹤0.01% 774
2016
Q4 		– Sell
-20,333
Closed -$2.4M – 896
2016
Q3 		$2.4M Buy
20,333
+6,181
+44% +$743K ﹤0.01% 711
2016
Q2 		$1.5M Sell
14,152
-134
-0.9% -$14.9K ﹤0.01% 729
2016
Q1 		$1.59M Buy
+14,286
New +$1.81M ﹤0.01% 710

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Massachusetts Financial Services's UTHR Position: Q3 2023 in Review

Massachusetts Financial Services sold out of United Therapeutics (UTHR) in Q3 2023, closing a stake of 8,066 shares — an estimated $1.78M sold.

Massachusetts Financial Services first reported a position in UTHR in Q1 2016 and held it in 27 quarters. The position peaked at $7.2M in Q4 2020. 508 funds tracked by Wall St. Rank hold UTHR as of Q3 2023.

  • Massachusetts Financial Services reported no remaining United Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 8,066 United Therapeutics shares in Q3 2023, an estimated $1.78M.
  • Massachusetts Financial Services first reported a position in United Therapeutics in Q1 2016 and held it in 27 quarters.
  • Massachusetts Financial Services's United Therapeutics position peaked at $7.2M in Q4 2020.
  • 508 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2023.

Based on Massachusetts Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.